Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic markers and putative therapeutic targets for hepatocellular carcinoma

21 Feb 2010

Abstract excerpt

Hepatocellular carcinoma (HCC) is the fifth most frequent human cancer and a fatal disease. Therapies with pharmacological agents do not improve the prognosis of patients with unresectable HCC. This emphasizes the need to identify new targets for early diagnosis, chemoprevention, and treatment of the disease. Available evidence indicates that clinical outcome of HCC could reflect the genetic predisposition to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to FOXO transcription factor regulation
Share to PI3K/AKT/mTOR signaling in cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20176048
DOI: 10.1016/j.mam.2010.02.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic markers and putative therapeutic targets for hepatocellular carcinomaPMID 20176048Read ↗

Genetic and epigenetic control of molecular alterations in hepatocellular carcinoma.Semantic proximity Read ↗

Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease.Semantic proximity Read ↗

Novel oncogenes and tumor suppressor genes in Hepatocellular Carcinoma: Carcinogenesis, progression, and therapeutic targetsSemantic proximity Read ↗

Molecular Pathways and Related Target Therapies in Liver CarcinomaSemantic proximity Read ↗

Diagnostic and Prognostic Molecular Markers in Hepatocellular CarcinomaSemantic proximity Read ↗

Diagnostic and prognostic molecular markers in hepatocellular carcinoma.Semantic proximity Read ↗

Hepatocellular carcinoma as a complex polygenic disease. Interpretive analysis of recent developments on genetic predisposition.Semantic proximity Read ↗

Pathology and pathogenesis of hepatocellular carcinoma.Semantic proximity Read ↗

The degradation of cell cycle regulators by SKP2/CKS1 ubiquitin ligase is genetically controlled in rodent liver cancer and contributes to determine the susceptibility to the disease.Semantic proximity Read ↗

Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC.Semantic proximity Read ↗

The Mutational and Transcriptional Landscapes of Hepatocarcinogenesis in a Rat ModelSemantic proximity Read ↗

Dissection of Signal Transduction Pathways as a Tool for the Development of Targeted Therapies of Hepatocellular CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.